Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists track new Drug's journey inside healthy volunteers

NCT ID NCT07508228

Not yet recruiting Knowledge-focused Sponsor: Pfizer Source: ClinicalTrials.gov ↗

Summary

This early-stage study aims to understand how a new drug, PF-07328948, is absorbed, broken down, and removed from the body. It will involve a small group of healthy adult male volunteers. Researchers will track a tiny, safe amount of a radioactive version of the drug to see exactly how it moves through the body after being taken by mouth or injection.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fortrea Clinical Research Unit Inc.

    Madison, Wisconsin, 53704, United States

Conditions

Explore the condition pages connected to this study.